Bio-Techne TECH
NASDAQ TECH
$72.83 +0.05 (+0.07%)
At close: Nov 9, 2026 · 4:00 PM EST

Bio-Techne (TECH) Asset Writedowns and Impairment (2012 - 2025)

Updated

Bio-Techne (TECH) reported Asset Writedowns and Impairment of $84.16 million for fiscal Q4 2025 (quarter ended Jun 30, 2025), up 428.5% from $15.93 million a year earlier.

Analysis

Bio-Techne (TECH) Asset Writedowns and Impairment (2012 - 2025) Analysis & Trends

For FY2025 (ended Jun 30, 2025), Bio-Techne posted Asset Writedowns and Impairment of $80.5 million, up 266.5% from FY2024.

  • Asset Writedowns and Impairment has a three-year compound annual growth rate of 62.6% (FY2022 to FY2025).
  • By fiscal year, Asset Writedowns and Impairment came in at $21.96 million in FY2024 and $18.72 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 267.71 Bn 244.23 Bn 5.13 Bn
2 Abbott Laboratories 191.69 Bn 165.56 Bn 7.39 Bn
3 Danaher 166.18 Bn 145.83 Bn 3.84 Bn
4 Intuitive Surgical 161.07 Bn 141.36 Bn 2.08 Bn
5 Medtronic 131.65 Bn 96.90 Bn 6.34 Bn
6 Stryker 125.25 Bn 111.44 Bn 4.25 Bn
7 Boston Scientific 63.85 Bn 59.29 Bn 3.43 Bn
8 Edwards Lifesciences 60.52 Bn 43.72 Bn 1.35 Bn
9 Becton Dickinson 59.08 Bn 56.23 Bn 2.32 Bn
10 Bio-Techne 11.36 Bn 10.57 Bn 211.39 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 84.16 Mn
Mar 31, 2025 -3.66 Mn
Jun 30, 2024 15.93 Mn
Dec 31, 2021 18.72 Mn
Sep 30, 2021 546,000.00
Mar 31, 2018 16.25 Mn
Mar 31, 2012 3.25 Mn
API Access

Bio-Techne Asset Writedowns and Impairment API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=asset-writedowns-and-impairment&ticker=TECH&period=max&api_key=YOUR_API_KEY